TY - JOUR
T1 - Enhanced genetic rescue of negative-strand RNA viruses
T2 - Use of an MVA-T7 RNA polymerase vector and DNA replication inhibitors
AU - Kovacs, Gerald R.
AU - Parks, Christopher L.
AU - Vasilakis, Nikos
AU - Udem, Stephen A.
PY - 2003/7/1
Y1 - 2003/7/1
N2 - A modified cDNA rescue system that improves recovery of recombinant nonsegmented, negative-strand RNA viruses from cloned DNAs is described. Rescue systems based on vaccinia virus-T7 RNA polymerase vectors have been used to derive many negative-strand viruses; however, some strains can be recalcitrant to rescue possibly because of the simultaneous replication of the vaccinia virus-T7 vector. Our goal was to engineer a system where replication of the vaccinia virus-T7 vector could be blocked, yet allow for sufficient T7 RNA polymerase expression to enable genetic rescue. To that end, a recombinant modified vaccinia virus Ankara (MVA) was engineered that contained the bacteriophage T7 gene-1 under the control of a strong early promoter that would enable T7 RNA polymerase expression in the absence of MVA DNA replication. The new T7 helper, MVAGKT7, was then utilized successfully for the genetic rescue of a measles virus minigenome and full-length cDNAs, in the presence of DNA synthesis inhibitors. In addition to blocking completely MVAGKT7 replication, AraC treatment was found to enhance minigenome-encoded gene expression and the efficiency of measles virus rescue.
AB - A modified cDNA rescue system that improves recovery of recombinant nonsegmented, negative-strand RNA viruses from cloned DNAs is described. Rescue systems based on vaccinia virus-T7 RNA polymerase vectors have been used to derive many negative-strand viruses; however, some strains can be recalcitrant to rescue possibly because of the simultaneous replication of the vaccinia virus-T7 vector. Our goal was to engineer a system where replication of the vaccinia virus-T7 vector could be blocked, yet allow for sufficient T7 RNA polymerase expression to enable genetic rescue. To that end, a recombinant modified vaccinia virus Ankara (MVA) was engineered that contained the bacteriophage T7 gene-1 under the control of a strong early promoter that would enable T7 RNA polymerase expression in the absence of MVA DNA replication. The new T7 helper, MVAGKT7, was then utilized successfully for the genetic rescue of a measles virus minigenome and full-length cDNAs, in the presence of DNA synthesis inhibitors. In addition to blocking completely MVAGKT7 replication, AraC treatment was found to enhance minigenome-encoded gene expression and the efficiency of measles virus rescue.
KW - Measles virus
KW - T7 RNA polymerase
KW - Vaccinia virus
UR - http://www.scopus.com/inward/record.url?scp=0037735244&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0037735244&partnerID=8YFLogxK
U2 - 10.1016/S0166-0934(03)00132-0
DO - 10.1016/S0166-0934(03)00132-0
M3 - Article
C2 - 12821194
AN - SCOPUS:0037735244
SN - 0166-0934
VL - 111
SP - 29
EP - 36
JO - Journal of Virological Methods
JF - Journal of Virological Methods
IS - 1
ER -